«Саратовский научно-медицинский журнал» » Архив номеров » Volume 9, issue 2 » Публикация

Поделиться публикацией:
Опубликовать в блог:
Опубликовано 2013-06-25 Опубликовано на SciPeople2013-09-09 16:42:26 ЖурналSaratov Journal of Medical Scientific Research


Improvement of complex therapy of patients with pathology of scrotal organs formed by chronic brucellosis infection
Glybochko Р. V., Evdokimov A.M., Liapina Е.Р., Shuldiakov A. A., Ponukalin A.N., Blyumberg В.I., Sedova L.N. / Антон Киселев контактное лицо
Glybochko Р. V., Evdokimov A.M., Liapina Е.Р., Shuldiakov A. A., Ponukalin A.N., Blyumberg В.I., Sedova L.N. Improvement of complex therapy of patients with pathology of scrotal organs formed by chronic brucellosis infection // Saratov Journal of Medical Scientific Research, Vol. 9, Issue 2, 2013, pp. 165-170
Аннотация The aim of the study is to improve the treatment of patients with male reproductive organs pathology, formed by chronic brucellosis infection. Material and methods: We have analyzed the dynamics of the clinical manifestations of diseases of the scrotal organs, data of physical and ultrasound studies, semen parameters, the quality of life in 22 patients with chronic brucellosis and the presence of orchitis / orchiepididymitis against conventional therapy (10 patients), and combined treatment with the inclusion of cycloferon (i/m, 2 injection rate from 5 (0.25g) with a break 10 days) — 12. Results: We have proved ability of cycloferon to reduce the severity of the inflammatory process in the testis and epididymis, with improving of spermatogenesis and the quality of life for patients. We have marked the reduction in the number of exacerbations of chronic orchitis / orchiepididymitis 2.4 times after the course of cycloferon, its good tolerability of patients, no side effects. Conclusion: Using these results, the presence of anti-inflammatory and immunomodulatory potencies, cycloferon can be recommended in treatment of inflammatory lesions of the scrotal organs in patients with chronic brucellosis.
Ключевые слова публикации:
       

Нет комментариев

Вам необходимо зайти или зарегистрироваться для комментирования